Latest News

  • TECHNOLOGY

    29 Oct 2025

    The Tiny Tech Turning Biologics Into Simple Shots
  • INSIGHTS

    27 Oct 2025

    Can Drug Delivery Go Green and Go Home?
  • RESEARCH

    24 Oct 2025

    The Science Behind Turning Needles Into Pills
  • INNOVATION

    17 Oct 2025

    Cancer Care in a Minute: Merck’s Keytruda Revolution

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

MARKET TRENDS

16 Oct 2025

A push to make high-dose biologics easier and faster to deliver

The Tiny Tech Turning Biologics Into Simple Shots

TECHNOLOGY

29 Oct 2025

The Tiny Tech Turning Biologics Into Simple Shots

Acquisition of Electrofi adds next-gen drug formulation and smart injection technology to Halozyme’s tech portfolio

Can Drug Delivery Go Green and Go Home?

INSIGHTS

27 Oct 2025

Can Drug Delivery Go Green and Go Home?

Portal, Kindeva, and Credence reshape biologic care with smarter, greener delivery

The Science Behind Turning Needles Into Pills

RESEARCH

24 Oct 2025

The Science Behind Turning Needles Into Pills

Researchers race to make complex injectable drugs work in pill form.

Cancer Care in a Minute: Merck’s Keytruda Revolution

INNOVATION

17 Oct 2025

Cancer Care in a Minute: Merck’s Keytruda Revolution

Merck’s new Keytruda shot cuts treatment time to a minute, transforming care deliver

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

MARKET TRENDS

16 Oct 2025

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

A push to make high-dose biologics easier and faster to deliver

The $900M Shot at Reinventing Biologic Delivery

TECHNOLOGY

15 Oct 2025

The $900M Shot at Reinventing Biologic Delivery

Halozyme’s Elektrofi deal could turn complex infusions into quick, patient-friendly injections

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.